Key result
Baseline sarcopenia is linked to ~41% higher risk of dementia after incident atrial fibrillation.
Why the study?
The association between sarcopenia and subsequent dementia after incident atrial fibrillation or flutter remained uncertain.
Is baseline sarcopenia associated with an increased risk of subsequent dementia in patients who develop incident atrial fibrillation or flutter?
Cohort (n=30,743)
Yes
Is baseline sarcopenia associated with an increased risk of subsequent dementia in patients who develop incident atrial fibrillation or flutter?
Pre-existing sarcopenia is independently associated with a 41% higher risk of developing all-cause dementia and a 64% higher risk of vascular dementia following a new diagnosis of atrial fibrillation or flutter.
Answers are grounded in this paper and cite their sources.
May inform dementia risk stratification after AF/flutter; leaves open whether sarcopenia interventions alter incidence in trials.
Background The association between sarcopenia and dementia after incident atrial fibrillation or flutter (AF/flutter) remains uncertain. Methods We studied 30,743 UK Biobank participants free of AF/flutter at recruitment who subsequently had a first recorded AF/flutter event. Sarcopenia was assessed at recruitment; dementia follow-up began at that event. Analyses used Cox and Fine–Gray models, propensity-score matching and restricted cubic splines. Exploratory analyses tested interactions with AF/flutter, heart failure and coronary artery disease status at entry. Results Sarcopenia was present in 2,279 participants (7.4%). Over a median 4.27 years after AF/flutter entry, 1,155 developed dementia. Recruitment preceded entry by a median 8.50 years. Fully adjusted analyses included 26,430 participants and 998 all-cause dementia events. Sarcopenia was associated with all-cause dementia in Cox (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.16–1.72) and Fine–Gray models (subdistribution HR, 1.31; 95% CI, 1.08–1.59). The matched Cox HR was 1.35 (95% CI, 1.09–1.66). Fully adjusted Cox HRs were 1.64 (95% CI, 1.15–2.35) for vascular dementia and 1.34 (95% CI, 0.92–1.93) for Alzheimer’s disease. No interactions with cardiovascular condition status were detected. Conclusions Sarcopenia assessed at recruitment was associated with all-cause dementia after incident AF/flutter. Prospective studies should assess the clinical value of muscle measurements near AF/flutter diagnosis.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted a cohort in Incident atrial fibrillation or flutter (AF/flutter) (n=30,743). Baseline sarcopenia vs. No baseline sarcopenia was evaluated on All-cause dementia after incident AF/flutter (HR 1.41, 95% CI 1.16-1.72). Baseline sarcopenia was associated with a higher risk of all-cause dementia after incident atrial fibrillation or flutter.
Synapse has enriched 10 related papers. Consider them for comparative context: